Ouch to the remaining shorts as it includes the UK ... LMAO
Melbourne, Australia; 23 February 2021: Starpharma (ASX: SPL, OTCQX: SPHRY) announced today it had received confirmation that the VIRALEZE™ antiviral nasal spray has been successfully registered for sale in Europe, including in the UK.
Ann: VIRALEZE antiviral nasal spray registered in Europe, page-2
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.10 |
Change
-0.060(2.78%) |
Mkt cap ! $877.0M | |||
| Open | High | Low | Value | Volume |
| $2.15 | $2.22 | $2.10 | $1.404M | 652.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3058 | $2.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.11 | 25755 | 1 |
View Market Depth
| Last trade - 16.10pm 02/03/2021 (20 minute delay) ? |
 (live)
|
|||||
|
Last
$2.11 |
Change
-0.060 ( 2.81 %) |
||||
| Open | High | Low | Volume | ||
| $2.16 | $2.22 | $2.10 | 146832 | ||
| Last updated 15.59pm 02/03/2021 (live) ? | |||||
| SPL (ASX) Chart |